Fidson Healthcare has declared a N3.6 billion dividend, or N1.50 per 50 kobo ordinary share, after reporting N119.06 billion in revenue for the 2025 financial year, the first time a Nigerian pharmaceutical company has passed the N100 billion annual revenue mark.
Founder and chairman Dr Fidelis Ayebae described 2025 as “a defining period in Fidson’s history” at the company’s annual general meeting, and thanked the Federal Government for improvements in the operating environment.
Managing director and chief executive Mr Biola Adebayo said Fidson “remained committed to sustaining growth through innovation, manufacturing excellence and strategic investments”, pointing to the company’s ambition to lead pharmaceutical manufacturing on the continent.
Shareholders at the meeting commended the board for maintaining the growth trajectory and for rewarding investors, and said they were confident in management’s ability to strengthen the company’s market position.
Fidson operates one of Nigeria’s larger local manufacturing plants at a time when the government is pushing zero-duty and zero-VAT incentives for health manufacturing to cut dependence on imported medicines. The result gives Nigeria’s listed health sector a rare scale benchmark, in a market where healthcare remains thinly represented on the Nigerian Exchange relative to banking and telecoms.
Why it matters: A Nigerian drugmaker clearing N100 billion in revenue signals that local manufacturing can reach investable scale, not just policy ambition.
Fidson Healthcare's Strong Performance and Expansion… Fidson Healthcare Plc has once again demonstrated its unwavering commitment to the pharmaceutical sector, announcing a profit of N4.187 billion for the financial year ending December 31, 2022. This impressive financial achievement was warmly received…
Fidson Healthcare Plc Partners with Chinese Firm to… In a strategic move aimed at addressing medical challenges associated with drug innovation for individuals living with the Human Immunodeficiency Virus (HIV), Fidson Healthcare Plc has announced a groundbreaking partnership with Chinese firm Jiangsu Aidea…
Breast Cancer Screening in Nigeria: Where to Go and Costs Breast cancer screening in Nigeria confuses people for a simple reason: nobody tells you which test you need. A woman of 32 asks for a mammogram and is told she does not need one. A…
Honoring a Healthcare Trailblazer: Pharm. Onyeka… In a world brimming with remarkable individuals, there are those whose impact transcends boundaries and leaves an indelible mark on everyone fortunate enough to cross paths with them. Today, we celebrate a true healthcare trailblazer,…
